CAMBRIDGE, Mass., Jan. 6, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman, chair and chief executive officer, will be presenting a company overview at the 27th Annual JP Morgan Healthcare Conference. Infinity's presentation will take place on Wednesday, January 14, 2009 at 1:30 p.m. (PST) (4:30 p.m. EST) at the Westin St. Francis in San Francisco, Calif.
A live webcast of Infinity's presentation will be accessible on the company's website at http://www.infi.com.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging cancer pathways. Infinity's two most advanced programs in Hsp90 inhibition and Hedgehog signaling pathway inhibition are evidence of its innovative approach to oncology drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.